About me...
27 y.o., swimmer
Striking Achievements
- Analyzing Biomolecular Ensembles, Methods Mol Biol. 2019;2022:415-451
- 2019-nowadays PhD Candidate at INSERM U1248 IPPRITT
- 2019 Medical Biotechnology MSc
- 2016 Molecular Bionics Engineering Bsc – “Planning, creating and analysing a database of chronic myeloid leukemia patients »
- 2018 Computer Science Engineering Bsc “Identifying and resolving named entities and senses in context“
- 2019 Medical Biotechnology MSc “Biased molecular dynamics simulations for investigating the ABCG2 transport”
- Language
- English (daily use, medical biotechnology thesis)
- German (passive)
- Hungarian (mother tongue)
- French (daily use within a year :-D)
RESEARCH ACTIVITIES
2019 INSERM U1248 IPPRITT, Limoges (France)
- Modelling membrane transport of MRP1, MRP2 and MRP4 by molecular dynamics and metadynamics simulations.
- Understanding of MRP1 transporter’s functioning and xenobiotic-transporter interactions at the atomic scale
Feb 2016 – Sep 2017/Feb 2018 – Jan 2019 MTA-SE Molecular Biophysics Research Group, Department of Biophysics and Radiation Biology, Semmelweis University, Budapest (Hungary)
-
Study of the ligand binding of proteins, which play a role in drug metabolism, with molecular dynamics and metadynamics simulations.
-
Investigation of the substrate recognition and transport of the ABCG2 multidrug transporter using docking and simulations.
-
Modelling of ABCG2.
Sep 2017 – Feb 2018 Computational Biology Laboratory at the Danish Cancer Society Research Center, Copenhagen (Denmark)
- Study of the BH3-domains of BH3-like proteins (ATG12, p14ARF and AMBRA1) with molecular dynamics and metadynamics simulations.
- Characterization of their behavior and their mutations.
- Investigation of different force fields and collective variables.
Feb 2015 – Jan 2016 MTA-SE Molecular Biophysics Research Group, Department of Biophysics and Radiation Biology, Semmelweis University, Budapest (Hungary)
- Planning, creating and analysing of a database of patients suffering from chronic myeloid leukaemia.